Form 4: Phreesia Executive Granted 66,000 RSUs

Phreesia's President of Provider Solutions, Evan Roberts, was granted 66,000 Restricted Stock Units vesting over four years.

Summary

• Evan Roberts, President of Provider Solutions at Phreesia, Inc. (PHR), was granted 66,000 Restricted Stock Units (RSUs).
• The transaction date for this grant was December 5, 2025.
• Each RSU represents the contingent right to receive one share of Phreesia's common stock.
• The RSUs vest in tranches: 10% on December 5, 2026, 20% on December 5, 2027, 30% on December 5, 2028, and 40% on December 5, 2029.
• Vesting is contingent upon Mr. Roberts' continued service to the Issuer through each vesting date.
• The grant was approved by the Compensation Committee of the Board of Directors on October 1, 2025.
• Following this transaction, Mr. Roberts beneficially owns 790,949 shares directly.

Sentiment

Score: 7

Explanation: The filing reports a routine executive compensation event (RSU grant). While not directly indicative of financial performance, it reflects positive aspects of executive retention and alignment with shareholder interests, which are generally viewed favorably. It does not contain negative financial news or significant new risks.

Positives

• The RSU grant aligns the executive's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The multi-year vesting schedule acts as a strong retention incentive for a key executive, ensuring continued leadership and stability.
• The grant was approved by the Compensation Committee, indicating proper corporate governance oversight of executive compensation.

Negatives

• The RSUs do not provide immediate liquidity or cash value to the executive until they vest and convert to shares.
• The vesting schedule means the executive does not fully own the granted shares for several years, subject to continued employment.

Risks

• The vesting of the RSUs is subject to the reporting person's continued service to the Issuer through each vesting date, meaning the executive could forfeit unvested units if employment ceases.

Future Outlook

The filing primarily details an executive compensation event and does not provide forward-looking statements regarding the company's financial performance or strategic direction, beyond the vesting schedule for the granted RSUs.

Industry Context

The grant of Restricted Stock Units (RSUs) is a common form of equity compensation for executives in the technology and healthcare IT sectors, including companies like Phreesia. This practice is widely used to attract, retain, and incentivize key talent by aligning their financial interests with the long-term performance of the company's stock.

Comparison to Industry Standards

• The RSU grant structure, with a multi-year vesting schedule contingent on continued service, is a standard practice in executive compensation across the technology and growth-oriented industries, comparable to compensation packages at companies like Veeva Systems or Cerner (now Oracle Health).
• The use of RSUs at a $0 price is typical for grants that represent future equity ownership, rather than an option exercise or direct purchase.
• The approval by a Compensation Committee aligns with best practices in corporate governance for executive remuneration, ensuring independent oversight.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the executive's interests with shareholders, potentially fostering long-term value creation and stability in leadership.
• Employees: The compensation structure for a key executive can set a precedent or signal the company's approach to incentivizing its leadership team.
• Executive (Evan Roberts): Receives a significant equity grant, providing a strong incentive for continued service and performance tied to the company's stock.

Next Steps

• The granted Restricted Stock Units will vest according to the specified schedule on December 5, 2026, 2027, 2028, and 2029, subject to continued service.

Key Dates

Recommendation

The filing reports a routine grant of Restricted Stock Units to an executive, which is a standard compensation practice aimed at executive retention and aligning interests with shareholders. This transaction does not provide new information that would significantly alter the investment outlook or warrant a change in recommendation for Phreesia stock. Investors should continue to evaluate the company based on its fundamental financial performance, market position, and strategic initiatives.

Keywords

Phreesia, PHR, Evan Roberts, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Stock Grant, Vesting